Shu Ning, PHD (she/her/hers)

University of California Davis Medical Center

University of California Davis California, USA
Ph.D. in Pharmacology and Toxicology 2018-2022
Imperial College London, Hammersmith Hospital London, UK
Master of Research with Distinction, major in Clinical Research (Translational Medicine) 2015-2016
Shenyang Pharmaceutical University, College of Pharmacy Shenyang, China
Bachelor of Science in Pharmacy, Overall GPA: 84.5/100, Class Rank: 2/32 2009-2014

Disclosure information not submitted.

Presentation(s):

• MP20-04: ARHGEF2 regulates lineage plasticity promoting neuroendocrine differentiation and treatment resistance in advanced prostate Cancer

  Friday, April 28, 2023
  3:30 PM – 5:30 PM CST